Consumer protection: unfair trade practices; insulin drug pricing report; require by the department of attorney general. Amends 1976 PA 331 (MCL 445.901 - 445.922) by adding sec. 9b.

This bill directs the Michigan Attorney General to investigate how prescription insulin drugs are priced and sold within the state to ensure fair consumer protections. To conduct this study, the Attorney General will gather data from insulin manufacturers, pharmacy benefit managers, and other relevant parties, while explicitly protecting trade secrets from being disclosed. By October 1, 2027, the Attorney General must publish a public report summarizing pricing practices and offering policy recommendations to prevent overpricing or unfair trade methods. The findings will be shared with state leaders and legislative committees to inform future decisions on health policy and potential law changes.